包虫病基因重组疫苗的研究  

Research on recombinant vaccines against hydatidosis

作　　者：德力夏提·依米提[1,2] 祖力皮也·吐尔逊[2] 张峰波[1] 曹春宝[2] 丁剑冰[1,2] 

机构地区：[1]新疆重大疾病医学重点实验室-省部共建国家重点实验室培育基地,新疆医科大学第一附属医院,乌鲁木齐830011 [2]新疆医科大学基础医学院,乌鲁木齐830011

出　　处：《中国病原生物学杂志》2013年第12期1130-1132,共3页Journal of Pathogen Biology

基　　金：国家自然科学基金项目(No.30901374,81160378,31000411,81060135,81160200,30860263);新疆维吾尔自治区高校重点学科项目(No.XYDXK50780328)

摘　　要：分子生物学技术的快速发展,使基因工程疫苗的研究更加深入。与此种新型疫苗相比传统疫苗已体现出预防效果不够理想,不容易保存,技术难度大,成本高等诸多缺陷。因此,对基因工程疫苗的开拓研究已成为当前疫苗领域的一个热点。本文简要概述了近年来包虫病基因工程疫苗研究现状及其发展前景。The rapid development of molecular biology techniques has led to further progress in the study of genetically engineered vaccines. Compared to these new vaccines, conventional vaccines have numerous drawbacks, e.g. they have less than ideal prophylactic action, they are hard to store, they involve highly complex production techniques, and they are expensive. Therefore, the study of genetically engineered vaccines has been highlighted in the current field of vaccines. This article provides a brief overview of recent developments in genetically engineered vaccines against hydatidosis, the present state of those vaccines, and their prospects for the future.

关 键 词：包虫病 基因工程 疫苗 综述 

分 类 号：R532.32[医药卫生—内科学]